# BridgeBio Oncology Therapeutics, Inc.: Form 8-K, filed May 12, 2026

- Company: [BridgeBio Oncology Therapeutics, Inc.](/companies/bbot.md) (CIK 1869105)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 17:07 ET
- Period: 2026-05-12
- Accession: 0001193125-26-219801
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1869105/000119312526219801/bbot-20260512.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1869105/000119312526219801/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1869105/000119312526219801/bbot-20260512.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-219801. Last ingested by Listed: Nov 5, 2026, 16:25 ET. No prices; not investment advice.